ATNM vs KMB · rev $35.0M vs P/E 19, rev $8.35B
Actinium Pharmaceuticals Inc (ATNM) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
ATNM currently screens at market cap $33.9M. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the ATNM and KMB stock pages for the full models.
Not investment advice.